1. Cholesterol esterification enzymes promote cancer growth and are potential therapeutic targets for repurposed drugs: a systematic review and meta-analysis of pre-clinical evidence. Issue 5 (2021) Authors: Websdale, A.; Chalmers, P.; Chen, X.; Kiew, Y.; Luo, X.; Mwarazi, R.; Wu, R.; Cioccoloni, G.; Røberg-Larsen, H.; Hughes, T.A.; Zulyniak, M.A.; Thorne, J.L. Journal: Proceedings of the Nutrition Society Issue: Volume 80:Issue 5(2021)Supplement OCE5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cholesterol side-chain hydroxylation is associated with expression of P-glycoprotein and disease-free survival in triple negative breast cancer patients. (2020) Authors: Websdale, A.; Hutchinson, S.A.; Lianto, P.; Roberg-Larsen, H.; Wastall, L.M.; Williams, B.; Rose, A.; Sharma, N.; Hughes, T.A.; Thorne, J.L. Journal: Proceedings of the Nutrition Society Issue: Volume 79(2020)Supplement OCE3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Overlap between nutrient metabolism and chemotherapy detoxification in triple negative breast cancer. Issue 5 (2021) Authors: Cioccoloni, G.; Websdale, A.; Soteriou, C.; Lianto, P.; Hutchinson, S.A.; Hughes, T.A.; Vasconcelos, E.J.R.; Forde, N.; Kim, B.; Zulyniak, M.A.; Thorne, J.L. Journal: Proceedings of the Nutrition Society Issue: Volume 80:Issue 5(2021)Supplement OCE5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Splicing of the cholesterol homeostasis protein LXR is a prognostic indicator for triple negative breast cancer patients. (2020) Authors: Lianto, P.; Hughes, T.A.; Moore, B.J.; Thorne, L.J. Journal: Proceedings of the Nutrition Society Issue: Volume 79(2020)Supplement OCE3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗